Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice

Monica Garcia-Alloza, Claudia Prada, Carli Lattarulo, Sara Fine, Laura A. Borrelli, Rebecca Betensky, Steven M. Greenberg, Matthew P. Frosch, Brian J. Bacskai

Research output: Contribution to journalArticle

Abstract

Cerebral amyloid angiopathy (CAA), characterized by extracellular β-amyloid peptide (Aβ) deposits in vessel walls, is present in the majority of cases of Alzheimer's disease and is a major cause of hemorrhagic stroke. Although the molecular pathways activated by vascular Aβ are poorly understood, extracellular matrix metalloproteinases (MMP) and Aβ-induced oxidative stress appear to play important roles. We adapted fluorogenic assays for MMP activity and reactive oxygen species generation for use in vivo. Using multiphoton microcopy in APPswe/PS1dE9 and Tg-2576 transgenic mice, we observed strong associations between MMP activation, oxidative stress, and CAA deposition in leptomeningeal vessels. Antioxidant treatment with α-phenyl-N-tert- butyl-nitrone reduced oxidative stress associated with CAA (∼50% reduction) without affecting MMP activation. Conversely, a selection of agents that inhibit MMP by different mechanisms of action, including minocycline, simvastatin, and GM6001, reduced not only CAA-associated MMP activation (∼30-40% reduction) but also oxidative stress (∼40% reduction). The inhibitors of MMP did not have direct antioxidant effects. Treatment of animals with α-phenyl-N- tert-butyl-nitrone or minocycline did not have a significant effect on CAA progression rates. These data suggest a close association between Aβ-related MMP activation and oxidative stress in vivo and raise the possibility that treatment with MMP inhibitors may have beneficial effects by indirectly reducing the oxidative stress associated with CAA.

Original languageEnglish (US)
Pages (from-to)1636-1647
Number of pages12
JournalJournal of Neurochemistry
Volume109
Issue number6
DOIs
StatePublished - Jun 1 2009

Fingerprint

Cerebral Amyloid Angiopathy
Oxidative stress
Matrix Metalloproteinases
Amyloid
Transgenic Mice
Oxidative Stress
Chemical activation
Minocycline
Matrix Metalloproteinase Inhibitors
Antioxidants
Simvastatin
Inhibition (Psychology)
Extracellular Matrix
Blood Vessels
Assays
Reactive Oxygen Species
Alzheimer Disease
Animals
Deposits
Stroke

Keywords

  • Antioxidant
  • Matrix metalloproteinases
  • MMP inhibitor
  • Multiphoton microscopy
  • Oxidative stress
  • Transgenic mouse

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. / Garcia-Alloza, Monica; Prada, Claudia; Lattarulo, Carli; Fine, Sara; Borrelli, Laura A.; Betensky, Rebecca; Greenberg, Steven M.; Frosch, Matthew P.; Bacskai, Brian J.

In: Journal of Neurochemistry, Vol. 109, No. 6, 01.06.2009, p. 1636-1647.

Research output: Contribution to journalArticle

Garcia-Alloza, M, Prada, C, Lattarulo, C, Fine, S, Borrelli, LA, Betensky, R, Greenberg, SM, Frosch, MP & Bacskai, BJ 2009, 'Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice', Journal of Neurochemistry, vol. 109, no. 6, pp. 1636-1647. https://doi.org/10.1111/j.1471-4159.2009.06096.x
Garcia-Alloza, Monica ; Prada, Claudia ; Lattarulo, Carli ; Fine, Sara ; Borrelli, Laura A. ; Betensky, Rebecca ; Greenberg, Steven M. ; Frosch, Matthew P. ; Bacskai, Brian J. / Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. In: Journal of Neurochemistry. 2009 ; Vol. 109, No. 6. pp. 1636-1647.
@article{b3aa280723cf4597a641f9e837de27ed,
title = "Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice",
abstract = "Cerebral amyloid angiopathy (CAA), characterized by extracellular β-amyloid peptide (Aβ) deposits in vessel walls, is present in the majority of cases of Alzheimer's disease and is a major cause of hemorrhagic stroke. Although the molecular pathways activated by vascular Aβ are poorly understood, extracellular matrix metalloproteinases (MMP) and Aβ-induced oxidative stress appear to play important roles. We adapted fluorogenic assays for MMP activity and reactive oxygen species generation for use in vivo. Using multiphoton microcopy in APPswe/PS1dE9 and Tg-2576 transgenic mice, we observed strong associations between MMP activation, oxidative stress, and CAA deposition in leptomeningeal vessels. Antioxidant treatment with α-phenyl-N-tert- butyl-nitrone reduced oxidative stress associated with CAA (∼50{\%} reduction) without affecting MMP activation. Conversely, a selection of agents that inhibit MMP by different mechanisms of action, including minocycline, simvastatin, and GM6001, reduced not only CAA-associated MMP activation (∼30-40{\%} reduction) but also oxidative stress (∼40{\%} reduction). The inhibitors of MMP did not have direct antioxidant effects. Treatment of animals with α-phenyl-N- tert-butyl-nitrone or minocycline did not have a significant effect on CAA progression rates. These data suggest a close association between Aβ-related MMP activation and oxidative stress in vivo and raise the possibility that treatment with MMP inhibitors may have beneficial effects by indirectly reducing the oxidative stress associated with CAA.",
keywords = "Antioxidant, Matrix metalloproteinases, MMP inhibitor, Multiphoton microscopy, Oxidative stress, Transgenic mouse",
author = "Monica Garcia-Alloza and Claudia Prada and Carli Lattarulo and Sara Fine and Borrelli, {Laura A.} and Rebecca Betensky and Greenberg, {Steven M.} and Frosch, {Matthew P.} and Bacskai, {Brian J.}",
year = "2009",
month = "6",
day = "1",
doi = "10.1111/j.1471-4159.2009.06096.x",
language = "English (US)",
volume = "109",
pages = "1636--1647",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice

AU - Garcia-Alloza, Monica

AU - Prada, Claudia

AU - Lattarulo, Carli

AU - Fine, Sara

AU - Borrelli, Laura A.

AU - Betensky, Rebecca

AU - Greenberg, Steven M.

AU - Frosch, Matthew P.

AU - Bacskai, Brian J.

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Cerebral amyloid angiopathy (CAA), characterized by extracellular β-amyloid peptide (Aβ) deposits in vessel walls, is present in the majority of cases of Alzheimer's disease and is a major cause of hemorrhagic stroke. Although the molecular pathways activated by vascular Aβ are poorly understood, extracellular matrix metalloproteinases (MMP) and Aβ-induced oxidative stress appear to play important roles. We adapted fluorogenic assays for MMP activity and reactive oxygen species generation for use in vivo. Using multiphoton microcopy in APPswe/PS1dE9 and Tg-2576 transgenic mice, we observed strong associations between MMP activation, oxidative stress, and CAA deposition in leptomeningeal vessels. Antioxidant treatment with α-phenyl-N-tert- butyl-nitrone reduced oxidative stress associated with CAA (∼50% reduction) without affecting MMP activation. Conversely, a selection of agents that inhibit MMP by different mechanisms of action, including minocycline, simvastatin, and GM6001, reduced not only CAA-associated MMP activation (∼30-40% reduction) but also oxidative stress (∼40% reduction). The inhibitors of MMP did not have direct antioxidant effects. Treatment of animals with α-phenyl-N- tert-butyl-nitrone or minocycline did not have a significant effect on CAA progression rates. These data suggest a close association between Aβ-related MMP activation and oxidative stress in vivo and raise the possibility that treatment with MMP inhibitors may have beneficial effects by indirectly reducing the oxidative stress associated with CAA.

AB - Cerebral amyloid angiopathy (CAA), characterized by extracellular β-amyloid peptide (Aβ) deposits in vessel walls, is present in the majority of cases of Alzheimer's disease and is a major cause of hemorrhagic stroke. Although the molecular pathways activated by vascular Aβ are poorly understood, extracellular matrix metalloproteinases (MMP) and Aβ-induced oxidative stress appear to play important roles. We adapted fluorogenic assays for MMP activity and reactive oxygen species generation for use in vivo. Using multiphoton microcopy in APPswe/PS1dE9 and Tg-2576 transgenic mice, we observed strong associations between MMP activation, oxidative stress, and CAA deposition in leptomeningeal vessels. Antioxidant treatment with α-phenyl-N-tert- butyl-nitrone reduced oxidative stress associated with CAA (∼50% reduction) without affecting MMP activation. Conversely, a selection of agents that inhibit MMP by different mechanisms of action, including minocycline, simvastatin, and GM6001, reduced not only CAA-associated MMP activation (∼30-40% reduction) but also oxidative stress (∼40% reduction). The inhibitors of MMP did not have direct antioxidant effects. Treatment of animals with α-phenyl-N- tert-butyl-nitrone or minocycline did not have a significant effect on CAA progression rates. These data suggest a close association between Aβ-related MMP activation and oxidative stress in vivo and raise the possibility that treatment with MMP inhibitors may have beneficial effects by indirectly reducing the oxidative stress associated with CAA.

KW - Antioxidant

KW - Matrix metalloproteinases

KW - MMP inhibitor

KW - Multiphoton microscopy

KW - Oxidative stress

KW - Transgenic mouse

UR - http://www.scopus.com/inward/record.url?scp=65949120942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65949120942&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2009.06096.x

DO - 10.1111/j.1471-4159.2009.06096.x

M3 - Article

VL - 109

SP - 1636

EP - 1647

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -